Immune stimulating macrolides
US11059844B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2018 |
| Grant date | Jul 13, 2021 |
| Priority date | — |
| Expiry date | Feb 22, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides immune stimulating macrolides of formula (I), wherein the substituents are as defined in the claims. The macrolides have utility in treating viral diseases and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.